TrialCancer science2025

Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.

Satoru Kitazono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.